CMEA Capital

Summary

In 1989 was created CMEA Capital, which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

Among the most popular portfolio startups of the fund, we may highlight Auspex Pharmaceuticals, Relypsa, Silicon Spice. Among the most successful fund investment fields, there are Pharmaceutical, Software. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The current fund was established by Tom Baruch. Besides them, we counted 3 critical employees of this fund in our database.

The fund is generally included in 2-6 deals every year. Comparing to the other companies, this CMEA Capital performs on 9 percentage points more the average number of lead investments. The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. The higher amount of exits for fund were in 2010. The high activity for fund was in 2008. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the CMEA Capital, startups are often financed by U.S. Venture Partners (USVP), Sofinnova Investments, Tavistock Life Sciences. The meaningful sponsors for the fund in investment in the same round are Redpoint, New Enterprise Associates, Sofinnova Investments. In the next rounds fund is usually obtained by U.S. Venture Partners (USVP), Presidio Partners, New Enterprise Associates.